During the past decade, Cleveland Clinic Respiratory Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Respiratory Institute" are "Pulmonary Arterial Hypertension" (2 trials), "COVID-19 Pneumonia" (1 trials) and "Homogeneous Emphysema" (1 trials). Many other conditions were trialed in "Cleveland Clinic Respiratory Institute" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Respiratory Institute" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ubenimex" (2 trials), "Biologic Lung Volume Reduction" (1 trials), "Placebo" (1 trials), "Tocilizumab (TCZ)" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Respiratory Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cleveland Clinic Respiratory Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cleveland Clinic Respiratory Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Respiratory Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".